Greenleaf Envi. (GREENLEAF)
Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹70 |
| Market Cap | ₹70.38 Cr |
| P/E Ratio | 11.14 |
| ROCE | 46.45% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Promoter Holding | 56.37% |
| 52-Week Range | ₹52.5 — ₹129 |
| Sector | Other Utilities |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹70, Greenleaf Envi wears a cheap multiple—P/E of 11.14 on a market cap of just ₹70 crore. But cheap can be a value trap if quality is missing. The return on capital employed is striking at 46.45%; that tells me the business earns well on the capital it deploys, a quality I admire. The latest quarter also shows sales of ₹21 crore and net profit of ₹3 crore, a margin of roughly 14%. Promoters hold 56.37%, so interests are aligned. Yet I must be honest: the scorecard is incomplete. There is no ROE, book value, or debt-to-equity data, and the Piotroski F-score is just 3 out of 9, which rings alarm bells about financial health. Sales and profit growth are both zero; there is no dividend to compensate while I wait. The 52-week range of ₹52.50 to ₹125.20 shows the stock has lost nearly half its value from the high—sometimes Mr. Market offers bargains, but sometimes he is telling you something. A zero-growth business at 11 times earnings is not obviously cheap if capital returns are deteriorating; the high ROCE needs auditing, not cheerleading. I would need evidence that flat profit is temporary, that receivables and operating cash flows are sound, and that the F-score is recovering. If Greenleaf can convert its impressive ROCE into steady growth and cash dividend, this could be a decent small-cap. Until then, I watch, I do not jump.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer